Insiders / Atlas Venture Fund XII, L.P.
Atlas Venture Fund XII, L.P.
CIK 1812049unknownbeneficial ownerinsider
Companies
3
First seen
Feb 11, 2021
Last activity
Aug 7, 2025
Companies
| Company | Shares held | Latest |
|---|---|---|
| Vigil Neuroscience, Inc. · VIGL | 4,808,896 | — |
| Aerovate Therapeutics, Inc. · AVTE | 2,327,909 | — |
| Gemini Therapeutics, Inc. /DE · GMTX | — | — |
All securities held
2 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Aerovate Therapeutics, Inc. | Common stock | 2,327,909 |
| Vigil Neuroscience, Inc. | Common stock | 4,808,896 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jul 2, 2021 | Buy Open-market buy | AVTE Aerovate Therapeutics, Inc. Common Stock | $7.50M | +536K +20.86% | 3,103,879 4.88% of shares | high |
| Jan 11, 2022 | Buy Open-market buy | VIGL Vigil Neuroscience, Inc. Common Stock | $7.49M | +535K +12.52% | 4,808,896 | high |
| Jul 15, 2022 | Other Other (per filing) | AVTE Aerovate Therapeutics, Inc. Common Stock |